SEARCH

SEARCH BY CITATION

References

  • 1
    Organ Procurement and Transplant Network. http://www.optn.org. Accessed March 29.
  • 2
    Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12: 27532758.
  • 3
    Hippen BE. In defense of a regulated market in kidneys from living vendors. J Med Philos 2005; 30: 593626.
  • 4
    Goodwin M. Altruism's limits: Law, capacity and organ commodification. Rutgers Law Rev 2004; 56: 307404.
  • 5
    Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: A cost-effectiveness analysis. Am J Transplant 2004; 4: 216221.
  • 6
    Cherry M. Kidney for sale by owner: Human organs, transplantation and the market. Washington , USA : Georgetown University Press, 2005.
  • 7
    Taylor JS. Stakes and kidneys: Why markets in human body parts are morally imperative. Live questions in ethics and moral philosophy. Aldershot , UK ; Burlington , VT : Ashgate Pub, 2005.
  • 8
    Wadström J, Gaston RS. Living donor kidney transplantation: Current practices, emerging trends and evolving challenges. London; New York : Taylor & Francis, 2005.
  • 9
    Fox RC, Swazey JP. Spare parts: Organ replacement in American Society. New York : Oxford University Press, 1992.
  • 10
    Delmonico FL, Arnold R, Scheper-Hughs N, Siminoff LA, Kahn J, Youngner SJ. Ethical incentives–not payment–for organ donation. N Engl J Med 2002; 346: 20022005.
  • 11
    Kass L. Life, liberty, and the defense of dignity: The challenge for bioethics. 1st ed. San Francisco : Encounter Books, 2002.